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Background: Bariatric operations mostly combine a restrictive gastric component with a rerouting of the
intestinal passage. The pylorus can thereby be alternatively preserved or excluded. With the aim of performing a
“pylorus-preserving gastric bypass”, we present early results of a proximal postpyloric loop duodeno-jejunostomy
associated with a sleeve gastrectomy (LSG) compared to results of a parallel, but distal LSG with a loop
duodeno-ileostomy as a two-step procedure.
Methods: 16 patients underwent either a two-step LSG with a distal loop duodeno-ileostomy (DIOS) as revisional
bariatric surgery or a combined single step operation with a proximal duodeno-jejunostomy (DJOS). Total small
intestinal length was determined to account for inter-individual differences.
Results: Mean operative time for the second-step of the DIOS operation was 121 min and 147 min for the
combined DJOS operation. The overall intestinal length was 750.8 cm (range 600-900 cm) with a bypassed limb
length of 235.7 cm in DJOS patients. The mean length of the common channel in DIOS patients measured 245.6
cm. Overall excess weight loss (%EWL) of the two-step DIOS procedure came to 38.31% and 49.60%, DJOS
patients experienced an %EWL of 19.75% and 46.53% at 1 and 6 months, resp. No complication related to the
duodeno-enterostomy occurred.
Conclusions: Loop duodeno-enterosomies with sleeve gastrectomy can be safely performed and may open new
alternatives in bariatric surgery with the possibility for inter-individual adaptation.Background
Bariatric surgery has proven to be the most effective
treatment for long-term weight loss and metabolic reba-
lancing in obese patients [1,2]. Most procedures com-
bine a restrictive gastric component with a rerouting
of the intestinal passage. Prominent examples are the
Roux-en-Y gastric bypass (RYGB) or the biliopancreatic
diversion (BPD). Gastric restriction either involves the
entire stomach therefore preserving the pylorus when
reconstructing the intestinal passage, or only the pro-
ximal part of the stomach is used to form a gastric
pouch thus leaving a remnant stomach. Passage recon-
struction then requires a gastro-enterostomy.* Correspondence: jodok.grueneberger@uniklinik-freiburg.de
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article, unless otherwise stated.Preserving the pylorus when bypassing the duodenum
has led to important technical changes in bariatric sur-
gery. In order to avoid a dumping syndrome and mar-
ginal ulcers that occasionally occurred after Scopinaro´s
initial BPD, Marceau et al. successfully changed the
technique to perform a biliopancreatic diversion with
duodenal switch (BPD/DS) with similar limb variations,
using however a postpyloric reconstruction [3].
The RYGB generally is one of the best established pro-
cedures in bariatric surgery [4]. However the failure rate
with weight regain due to a dilatation of the gastric pouch,
gastro-jejunostomy and proximal jejunum is up to 35%
[5]. Recently, bile reflux was identified as one important
cause of postoperative pain [6]. Again, a postpyloric re-
construction seems tempting for this procedure.
We here present perioperative data of a proximal
(similar to RYGB) and distal (similar to BPD/DS) post-
pyloric loop duodeno-enterostomy with sleeve gastrec-
tomy. The distal duodeno-enterostomy, based on theentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
Figure 1 Diagram of a duodeno-jejunostomy with sleeve
gastrectomy (DJOS). The bypassed intestinal length (1/3 of overall
intestinal length) is labelled in red.
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associated to a sleeve gastectomy (SADI-S) operation
[7], was performed as revisionary bariatric operation.
Methods
Patients
From October 2011 to September 2012, 16 patients
underwent loop duodeno-enterostomies for bariatric
surgery. Explicit written informed consent for operation
and data recording was obtained from all patients. Data
recording and evaluation was approved by the ethics
committee of the University of Freiburg (ref. number
321/13) and was in accordance with the Declaration of
Helsinki. A proximal duodeno-jejunostomy with sleeve
gastrectomy (DJOS) was conducted as an alternative to
RYGB in 7 selected patients eligible for bariatric surgery
with a body mass index (BMI) range from 35.7 to 47.9
kg/m2 (median BMI 42.7 kg/m2). In case of previous
gastric banding and relevant perigastric scar tissue,
instead of a sleeve gastrectomy, a gastric plicature was
performed (n = 3/7) to minimize operative risk. Two-
step DIOS was performed as revisionary surgery after
failed RYGB due to dumping syndrome (n = 2/9) or after
sleeve gastrectomy with insufficient weight loss alone
(3/9) or in combination with persisting type 2 diabetes
(T2DM, 4/9). All operations were performed by the
same senior surgeon. In order to prevent vitamin defi-
ciencies, besides a multivitamin, patients are prescribed
Calcium (500 mg twice daily), Vitamin D3 (1000 IU
daily), folic acid (5 mg daily) and iron (100 mg daily)
supplementation.
Data recording included length of hospital stay,
preoperative BMI, presence of medical comorbidities,
intra- and postoperative complications, management of
complications, total operative time, common channel
length and weight loss. Total intestinal length was
recorded only after February 2012. All data were entered
prospectively into a custom-designed database. The
patients had the same follow-up protocol at the out-
patient clinic at 1, 3, 6, and 12 months after surgery,
followed by an annual visit.
Operative technique
The patient is placed in the split-leg position with the
operating surgeon standing between the legs. Trocar
positions are similar to those used for banded sleeve
gastrectomy [8].
Sleeve gastrectomy is conducted as described earlier
[8]. In case of a stomach plication, we use a modified
technique described by Talebpour et al. applying at
least two rows of plication using a 3-0 V-Loc™ Suture
(Covidien, Dublin, Ireland) [9]. The second part of the
operation (second step, when performing a two-step
procedure) begins with separation of the duodenumwith an endostapling device (GIA- Roticulators,
Covidien, Dublin, Ireland, violet cartridge) under pre-
servation of the right gastric artery. Before performing
the duodeno-enterostomy, the length of the small bowel
is determined to account for inter-individual differ-
ences. After measurement, the omega loop should be
placed near the postpyloric duodenum with special at-
tention to intestinal alignment to avoid mesenteric mal-
rotation. The position of the duodeno-enterostomy is
determined to be aboral to the Treitz ligament, 1/3 of
total small bowel length for DJOS (Figure 1), and 2/3
for DIOS (Figure 2). The duodeno-enterostomy is per-
formed as an antecolic, continuous end-to-side hand-
sewn anastomosis using 3-0 V-loc™ sutures (Covidien,
Dublin, Ireland, Figure 3). Diluted half-strength methy-
lene blue dye (150-200 ml) is used for leak testing.
Finally, a drain is put towards the duodenal stump. In
case of a two-step procedure, the second part of the
operation is conducted separately, then sparing the top
left 5 mm trocar needed for sleeve gastrectomy.
Figure 2 Diagram of a duodeno-ileostomy with sleeve
gastrectomy (DIOS). The bypassed intestinal length (2/3 of overall
intestinal length) is labelled in red.
Figure 3 Final aspect of the duodeno-enterostomy.
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Prism 5 for Mac OS X (GraphPad Software, Inc.) was
used for all statistical analyses. Statistical significance
was set at an alpha of 0.05 for all analyses.
Results
16 patients underwent laparoscopic DIOS and DJOS op-
erations with a mean duration of 121 min and 147 min,
respectively. Overall, 9 patients had undergone previous
weight loss surgery, mainly gastric banding (Table 1). A
complex gastric reconstruction from RYGB to a sleeve
stomach due to uncontrolled dumping syndrome had
been conducted earlier in 2 patients. The mean latency
between the sleeve and the second step DIOS operation
was 17.9 months (Table 1).
One intestinal perforation occurred upon insertion of
the first trocar in a patient with previous gastric banding
and subsequent adhesions to the abdominal wall. No
complications specific to the duodeno-enterostomy were
noted (Table 2).Intestinal length
The overall total intestinal length was 750.8 cm (Table 2).
Although there was no correlation of total intestinal
length and preoperative bodyweight (linear regression
p = 0.76), the total small intestinal length in DIOS pa-
tients was significantly longer than in DJOS patients
(Mann-Whitney P = 0.038, Table 2).
Weight loss
The mean preoperative BMI was 40.63 kg/m2 in DIOS
and 41.60 kg/m2 in DJOS patients (Table 1). Patients after
primary DJOS operation presented with an excess weight
loss (%EWL) of 19.75% and 46.53% at 1 and 6 months
(Figure 4A). The overall %EWL of the combined DIOS
procedure was 38.31% and 49.60% (Figure 4B). Mean
weight loss through LSG alone was 31.73% (range -2.67 -
69.54). Further %EWL came to 18.73% at 1 and 33.03%
at 6 months following the second step operation. In this
early follow-up, 1 patient did not lose any additional
weight after the second step operation despite bypassing
520 cm of small intestine and clinical signs of malabsorp-
tion. Furthermore, control CT sleeve volumetry revealed a
small volume of 142 ml at 10 months postoperatively indi-
cating sustained restriction.
Comorbidities
Prior to LSG, 88.9% of patients suffered from T2DM. At
the time of the second-step DIOS operation, 44.4% had
remained on anti-diabetic medication, 33.3% on insulin
therapy (Table 3). 3 months after completion of the sec-
ond step, only 11.1% (1 patient) still needed anti-diabetic
medication. Glycated haemoglobin levels dropped from
6.8% to 5.7% in DIOS and from 8.0% to 6.9% in DJOS
patients 6 months after the operation (both NS). LSG
alone led to a relief of arterial hypertension in 50% of
DIOS patients, with 3 patients remaining on antihyper-
tensive drugs up to the second step operation. Only 1
Table 1 Patient characteristics
DIOS DJOS Overall
Patients 9 7 (gastric plicature: n = 3) 16
Male/Female 3/6 1/6 4/12
Age 52 44 49
Body weight prior to duodeno-enterostomy 114.2 kg (85 – 145 kg) 117.4 kg (103 – 145 kg)
BMI prior to duodeno-enterostomy 40.63 kg/m2 (33.20 – 55.94 kg/m2) 41.60 kg/m2 (35.74 – 47.90 kg/m2)
Body weight prior to LSG 140.1 kg (105 – 175 kg)
Gap between LSG and DIOS 17.9 months (3.65 – 41.96 months)
%EWL before 2nd step surgery 31.73% (-2.67 – 69.54)
Previous bariatric surgery 5 of 9 (gastric ballon 2, LGB 1, RYGB 2) 4 of 7 (LGB 4) 9 of 16
Values are expressed as means; laparoscopic gastric banding (LGB), Roux-en-Y gastric bypass (RYGB), % excess weight loss (%EWL).
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after the DIOS operation. Interestingly, this is the same
patient who also had to continue insulin treatment.
Reflux was present in the majority of patients (Table 3)
with overall 87.5% of patients requiring proton-pump-
inhibiting treatment. Corresponding to the shorter com-
mon channel, diarrhoea was present in 66.7% of DIOS
and in 28.6% of DJOS patients. Overall, 62.5% of patients
complaining of diarrhoea reported only occasional epi-
sodes. Occasional episodes of dumping were reported by
only 1 patient after a DJOS operation.
Discussion
Major bariatric surgery combines a restrictive gastric com-
ponent with a rearrangement of the small intestinal pas-
sage. Whenever reconnecting the stomach pouch to the
intestine, the pylorus can either be preserved (BPD-DS),
or excluded, as it is after common RYGB and Mini-
Gastric-Bypass (MGB) [3,10]. In order to preserve the pyl-
orus for a bypass-like procedure, we combined a LSG with
an end-to-side duodenojeunostomy – DJOS.
Why should the pylorus be preserved? Historically, this
debate was initiated after Watson introduced a pylorus-Table 2 Perioperative data
DIOS
Surgical complication 0 of 9
Operative revision 0 of 9
Expansion on surgery 5 of 9 (cholecystectomy 3, appendectom
repair 1, end-to-end jejunojejunosto
Duration of surgery 120.6 min
Length of small intestine 808.3 cm (range: 760 – 85
Length of bilio-pancreatic channel 538.3 cm
Length of common channel 245.6 cm
Values are expressed as means or absolute numbers.
ΨMann-Whitney test DIOS vs. DJOS.preserving alternative to the classic Whipple procedure in
performing a pancreatic head resection [11]. This modifi-
cation should prevent the patient from typical post-
gastrectomy symptoms such as dumping, diarrhoea and
dyspepsia [12]. A prospective randomized trial comparing
the two procedures could later demonstrate an increased
quality of life regarding appetite, nausea and diarrhoea
resulting in a faster regain of bodyweight [13]. For baria-
tric surgery, Hess et al. demonstrated a reduction of mar-
ginal ulcers by 90% and no dumping syndrome when the
pylorus was preserved during a BPD/DS [14].
Postpyloric anastomosis furthermore allows for loop
reconstruction, whereas a “prepyloric” gastro-entero
anastomosis necessitates rerouting the biliopancreatic
fluids via a foot-point or a Roux-en-Y reconstruction to
avoid biliary reflux. Disregarding this principle, surgeons
use a loop reconstruction without rerouting biliopan-
creatic fluids in performing a MGB [10,15]. Although
this operation enables excellent weight loss with a low
complication rate, operative revision after MGB was
mostly due to internal bile reflux and marginal ulcers
[16]. Marginal ulcers furthermore also occur after con-
ventional RYGB in about 13% of patients, even though aDJOS Overall
1 of 7 (trocar perforation) 1 of 16 (6.3%)
1 of 7 1 of 16 (6.3%)
y 2, umbilical hernia
my after RYGB 1)
1 of 7
(gastric band removal 1)
147 min P = 0.112Ψ
0 cm) 701.4 cm
(range: 600 – 900 cm)
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Figure 4 Box-Whisker-plot of % excess weight loss (%EWL).
A: %EWL of the DJOS and B: cumulative %EWL of the two-step DIOS
procedure.
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patients [17].
Furthermore, pylorus preservation leaves a physio-
logical control mechanism of food output into the small
intestine preventing a dumping syndrome [18]. Dumping
syndrome is an important issue after RYGB and the
overall incidence may rise up to 75.9% [19]. Recently,
a detailed examination of postoperative dumpingTable 3 Morbidity
DIOS
Flatulence 55.6% (all regularly)
Dumping 0%
Diarrhoea 66.7% (2 regularly, 4 occ.)
Reflux 44.4%
PPI treatment 100%
Values are expressed as fractions with subgroup differentiation in absolute number
τFisher´s exact test DIOS vs. DJOS.syndrome showed severe problems of fatigue in 12% of
patients 2 years after RYGB [20]. The current analysis
of postoperative bowel habits after DJOS operations
revealed that only 1 patient complained of occasional
dumping-related symptoms.
Surprisingly, reflux was present in 86% of patients
after the DJOS operation, despite PPI treatment and
grossly asymptomatic patients preoperatively. Although
we cannot test for this hypothesis, we believe that reflux
is a consequence of the LSG in which it is a common
phenomenon [21]. However, the reflux incidence in our
own isolated LSG collective is much lower and other
authors report an incidence of 25-47% [21,22]. We ear-
lier demonstrated a thoracic sleeve migration as a cause
of reflux after LSG [23]. Although performing only a
limited duodenal mobilisation maintaining the right gas-
tric artery, disruption at the duodenum and pyloric mo-
bilisation may facilitate such a migration. Long-term
follow up with close attention on reflux including struc-
tured analysis such as 24-hour pH-manometry will fur-
ther clarify the cause of increased reflux and show,
whether these high numbers indeed prove to be an obs-
tacle after DJOS operations.
In the current series, a gastric plicature was used in 3
patients after previous gastric banding. This constella-
tion is a known risk factor for sleeve leak when perfor-
ming a conventional LSG [24,25]. Gastric plicature has
been introduced by Talebpour et al. as an alternative to
LSG [9]. Weight loss through this technique alone may
be inferior to conventional sleeve gastrectomy and ran-
domized controlled trials have not been conducted to
date [26]. However, in case of previous gastric banding
and relevant perigastric scar tissue, a gastric plicature
may pose an alternative to LSG as the stomach and sur-
rounding scar tissue has not to be cut, especially when
combined with additional bariatric options such as a
rerouting of the intestine. Certainly to date, this option
is relevant only for individual patient cases.
This early follow-up period of 6 months in a small
and heterogeneous group does not allow for valid eva-
luation of weight loss capacity, yet weight loss noted
after DJOS is within the range reported by othersDJOS
71.4% (1 regularly, 4 occ.)
14.3% (all occ.)
28.6% (1 regularly, 1 occ.)
85.7% P = 0.145τ
71.4%
(peramphases).
Grueneberger et al. BMC Surgery 2014, 14:20 Page 6 of 8
http://www.biomedcentral.com/1471-2482/14/20following RYGB [27,28]. Overall %EWL of DIOS pa-
tients was considerably lower when compared to
Sachez-Peraut´s SADI-S collective, yet again the ma-
jority of patients had undergone pervious weight loss
surgery which is known to considerably effect weight
loss [7].
Weight regain is a major problem after conventional
gastric bypass with up to 35% of patients experiencing
an %EWL less than 60%. Causes noted are dilatation of
the gastric pouch or enlargement of the gastro-jejunal
anastomosis [29]. Clinically, we and others observe that
patients regaining weight after RYGB have often lost
their feeling of satiety and subsequently consume large
meals [5]. We speculate that the DJOS operation has
two distinct advantages targeting these drawbacks after
conventional RYGB: 1. Anastomotic dilatation will be
prevented through pyloric physiological muscle calibra-
tion and, 2. LSG is known to create an excellent feeling
of satiety due to a deceleration of food transit in the lon-
gitudinal part of the sleeve stomach [30].
The major predicament in analysing limb-length varia-
tions is the fact that surgeons creating a gastric bypass
commonly measure the alimentary and biliopancreatic
limb but neglect the common channel length. Surgeons
forming a BPD, by contrast, determine the length of the
common channel and alimentary limb, and in turn neg-
lect the length of the biliopancreatic limb. Furthermore,
the total small intestinal length is highly variable and
ranges between 4 to nearly 10 meters [31]. We measured
a comparable range of small bowel length of 6-9 m,
yet the length variation of bowel measured was large.
Compared to the historical measurement of small bowel
length in lean adults, the total small bowel length of
obese patients was comparable to lean individuals [32].
Establishing the loop duodeno-jejunostomy the key
issue was to determine an adequate anastomosis pos-
ition. In conventional RYGB, weight loss is mainly due
to calorie restriction, which is substantially caused by
appetite control due to a modulation of entero-endo-
crine peptides, mainly located in the terminal ileum
[33]. As this modulation is well known for current limb
length variations in RYGB, the focus was to find an
anastomosis position similar to conventional RYGB.
Here, the alimentary limb ranges from 75 cm to 150 cm
with a biliopancreatic limb length of approximately 30
cm [34]. Randomized controlled trials suggest that a
long alimentary limb (150 cm) might be preferable for
the super-obese [35,36]. However, Stefinidis et al.
reviewing the “Importance of the Length of the Limbs
for Gastric Bypass Patients” find no clear recommen-
dation [34]. In MGB, the gastro-jejunostomy in usually
formed at 150 cm [10]. Some authors suggest an
increase in length by 10 cm for every BMI point above
40 kg/m2 (MGB for all) [15].To account for inter-individual differences, as outlined
above, we decided to place the duodeno-jejunostomy
after 1/3 of small bowel length, bypassing an average of
236 cm in performing a DJOS operation. Taking into
account that the loop reconstruction combines the
alimentary and biliopancreatic limb, DJOS resembles a
long limb RYGB (150 cm plus 30 cm).
For the malabsorptive DIOS operation, the adequate
anastomosis position had to be carefully selected in
order to prevent excessive malabsorption. As there is no
alimentary limb when conducting a loop reconstruction,
the common channel had to be considerably longer than
in classic BPD surgery. Sanchez-Pernaute et al. exten-
sively reviewed limb length variations when initially
describing the SADI-S operation, ultimately deciding to
form a common channel of 200 cm [37]. As the SADI-S
operation has proven to be safe and effective with no
relevant malabsorption in mid-term follow up, anasto-
mosis position for the DIOS operation should be similar
[7]. Yet, provided that the overall proportional energy
resorption of food consumed does not grossly depend
on bowel length, it seems consistent that leaving a
200 cm common channel at a total bowel length of
500 cm causes greater possible malabsorption than the
same common channel at 900 cm overall bowel length.
Based on the considerations above, we decided to
place the duodeno-ileostomy after 2/3 of the small intes-
tine, leaving a common channel of 1/3. For maximum
safety, the common channel was never under 200 cm in
length. The 2/3 position left a mean common channel
length of 245 cm, thus approximately 20% more com-
pared to the SADI-S operation [7].Conclusions
Although two different metabolic principles underlie the
DJOS and DIOS operation, performing loop duodeno-
enterostomies with sleeve gastrectomy essentially breaks
down bariatric surgery into exactly these two distinct ele-
ments, leaving the possibility for individual adaptation.
The early results of this small and heterogeneous series
most importantly show no mortality and no complication
related to the duodeno-enterostomy. Pylorus-preserving
duodeno-enterostomies with sleeve gastrectomy may open
new technical alternatives in bariatric surgery. If the DJOS
and DIOS operations prove to be beneficial will have to be
evaluated in randomized controlled trials.
Abbreviations
BMI: Body mass index; BPD: Biliopancreatic diversion; BPD/DS: Biliopancreatic
diversion with duodenal switch; CT: Computed tomograpy; DIOS: Duodeno-
ileostomy with sleeve gastrectomy; DJOS: Duodeno-jejunostomy with
sleeve gastrectomy; LSG: Laparsocopic sleeve gastrectomy; MGB: Mini
gastric bypass; RYGB: Roux-en-Y gastric bypass; SADI-S: Single anastomosis
duodeno-ileostomy associated to a sleeve gastectomy; %EWL: Excess
weight loss.
Grueneberger et al. BMC Surgery 2014, 14:20 Page 7 of 8
http://www.biomedcentral.com/1471-2482/14/20Competing interests
Jodok Matthias Grueneberger, Iwona Karcz-Socha, Goran Marjanovic, Simon
Kuesters, Krystyna Zwirska-Korczala, Katharina Schmidt and W. Konrad Karcz
have no conflicts of interest.Authors’ contributions
MG, GM, SK and KK participaed as surgeons for DIOS and DJOS operations,
MG, KS and KK have drafted the manuscript, IK-S and KZ-K critically revised
the manuscript. All authors read and approved the final manuscript.
Author details
1Department of General and Visceral Surgery, University of Freiburg,
Hugstetter Strasse 55, 79106 Freiburg, Germany. 2Department of Physiology,
Silesian Medical University, Katowitz, Poland. 3Department of General
Surgery, University of Schleswig-Holstein, Campus Lübeck, Lübeck, Germany.
Received: 11 September 2013 Accepted: 27 March 2014
Published: 11 April 2014References
1. Mingrone G, Panunzi S, De Gaetano A, Guidone C, Iaconelli A, Leccesi L,
Nanni G, Pomp A, Castagneto M, Ghirlanda G, Rubino F: Bariatric surgery
versus conventional medical therapy for type 2 diabetes. N Engl J Med
2012, 366:1577–1585.
2. Sjostrom L, Lindroos AK, Peltonen M, Torgerson J, Bouchard C, Carlsson B,
Dahlgren S, Larsson B, Narbro K, Sjostrom CD, Sullivan M, Wedel H, Swedish
Obese Subjects Study Scientific Group: Lifestyle, diabetes, and
cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med
2004, 351:2683–2693.
3. Marceau P, Biron S, Bourque RA, Potvin M, Hould FS, Simard S:
Biliopancreatic Diversion with a New Type of Gastrectomy. Obes Surg
1993, 3:29–35.
4. Padwal R, Klarenbach S, Wiebe N, Birch D, Karmali S, Manns B, Hazel M,
Sharma AM, Tonelli M: Bariatric surgery: a systematic review and
network meta-analysis of randomized trials. Obes Rev 2011,
12:602–621.
5. Christou NV, Look D, Maclean LD: Weight gain after short- and long-limb
gastric bypass in patients followed for longer than 10 years. Ann Surg
2006, 244:734–740.
6. Swartz DE, Mobley E, Felix EL: Bile reflux after Roux-en-Y gastric bypass:
an unrecognized cause of postoperative pain. Surg Obes Relat Dis 2009,
5:27–30.
7. Sanchez-Pernaute A, Herrera MA, Perez-Aguirre ME, Talavera P,
Cabrerizo L, Matia P, Diez-Valladares L, Barabash A, Martin-Antona E,
Garcia-Botella A, Garcia-Almenta EM, Torres A: Single anastomosis
duodeno-ileal bypass with sleeve gastrectomy (SADI-S). One to
three-year follow-up. Obes Surg 2010, 20:1720–1726.
8. Karcz WK, Marjanovic G, Grueneberger J, Baumann T, Bukhari W,
Krawczykowski D, Kuesters S: Banded sleeve gastrectomy using the GaBP
ring–surgical technique. Obes Facts 2011, 4:77–80.
9. Talebpour A, Motamedi SM, Vahidi H: Twelve year experience of
laparoscopic gastric plication in morbid obesity: development of the
technique and patient outcomes. Ann Surg Innov Res 2012, 6:7.
10. Rutledge R, Walsh TR: Continued excellent results with the mini-
gastric bypass: six-year study in 2,410 patients. Obes Surg 2005,
15:1304–1308.
11. Watson K: Carcinoma of ampulla of vater successful radical resection.
Brit J Surg 1944, 31:368–373.
12. Traverso LW, Longmire WP Jr: Preservation of the pylorus in
pancreaticoduodenectomy. Surg Gynecol Obstet 1978, 146:959–962.
13. Wenger FA, Jacobi CA, Haubold K, Zieren HU, Muller JM:
[Gastrointestinal quality of life after duodenopancreatectomy in
pancreatic carcinoma. Preliminary results of a prospective
randomized study: pancreatoduodenectomy or pylorus-preserving
pancreatoduodenectomy]. Chirurg 1999, 70:1454–1459.
14. Hess DS, Hess DW: Biliopancreatic diversion with a duodenal switch.
Obes Surg 1998, 8:267–282.
15. Noun R, Skaff J, Riachi E, Daher R, Antoun NA, Nasr M: One thousand
consecutive mini-gastric bypass: short- and long-term outcome.
Obes Surg 2012, 22:697–703.16. Johnson WH, Fernanadez AZ, Farrell TM, Macdonald KG, Grant JP,
McMahon RL, Pryor AD, Wolfe LG, DeMaria EJ: Surgical revision of
loop (“mini”) gastric bypass procedure: multicenter review of
complications and conversions to Roux-en-Y gastric bypass.
Surg Obes Relat Dis 2007, 3:37–41.
17. Obeid A, Long J, Kakade M, Clements RH, Stahl R, Grams J: Laparoscopic
Roux-en-Y gastric bypass: long term clinical outcomes. Surg Endosc 2012,
26:3515–3520.
18. Shah M, Simha V, Garg A: Review: long-term impact of bariatric surgery
on body weight, comorbidities, and nutritional status. J Clin Endocrinol
Metab 2006, 91:4223–4231.
19. Mallory GN, Macgregor AM, Rand CS: The Influence of Dumping on
Weight Loss After Gastric Restrictive Surgery for Morbid Obesity.
Obes Surg 1996, 6:474–478.
20. Laurenius A, Olbers T, Naslund I, Karlsson J: Dumping syndrome following
gastric bypass: validation of the dumping symptom rating scale.
Obes Surg 2013, 23:740–755.
21. Carter PR, LeBlanc KA, Hausmann MG, Kleinpeter KP, deBarros SN, Jones SM:
Association between gastroesophageal reflux disease and laparoscopic
sleeve gastrectomy. Surg Obes Relat Dis 2011, 7:569–572.
22. Himpens J, Dobbeleir J, Peeters G: Long-term results of laparoscopic
sleeve gastrectomy for obesity. Ann Surg 2010, 252:319–324.
23. Baumann T, Grueneberger J, Pache G, Kuesters S, Marjanovic G,
Kulemann B, Holzner P, Karcz-Socha I, Suesslin D, Hopt UT, Langer M,
Karcz WK: Three-dimensional stomach analysis with computed
tomography after laparoscopic sleeve gastrectomy: sleeve dilation
and thoracic migration. Surg Endosc 2011, 25:2323–2329.
24. Alevizos L, Linardoutsos D, Menenakos E, Stamou K, Vlachos K, Zografos G,
Leandros E: Routine abdominal drains after laparoscopic sleeve
gastrectomy: a retrospective review of 353 patients. Obes Surg 2011,
21:687–691.
25. Goitein D, Feigin A, Segal-Lieberman G, Goitein O, Papa MZ, Zippel D:
Laparoscopic sleeve gastrectomy as a revisional option after gastric
band failure. Surg Endosc 2011, 25:2626–2630.
26. Shen D, Ye H, Wang Y, Ji Y, Zhan X, Zhu J, Li W: Comparison of short-term
outcomes between laparoscopic greater curvature plication and
laparoscopic sleeve gastrectomy. Surg Endosc 2013, 27:2768–2774.
27. Brethauer SA, Heneghan HM, Eldar S, Gatmaitan P, Huang H, Kashyap S,
Gornik HL, Kirwan JP, Schauer PR: Early effects of gastric bypass on
endothelial function, inflammation, and cardiovascular risk in obese
patients. Surg Endosc 2011, 25:2650–2659.
28. Lakdawala MA, Bhasker A, Mulchandani D, Goel S, Jain S: Comparison
between the results of laparoscopic sleeve gastrectomy and
laparoscopic Roux-en-Y gastric bypass in the Indian population:
a retrospective 1 year study. Obes Surg 2010, 20:1–6.
29. Kuesters S, Grueneberger JM, Baumann T, Bukhari W, Daoud M, Hopt UT,
Karcz WK: Revisionary bariatric surgery: indications and outcome of 100
consecutive operations at a single center. Surg Endosc 2012,
26:1718–1723.
30. Baumann T, Kuesters S, Grueneberger J, Marjanovic G, Zimmermann L,
Schaefer AO, Hopt UT, Langer M, Karcz WK: Time-resolved MRI after
ingestion of liquids reveals motility changes after laparoscopic sleeve
gastrectomy–preliminary results. Obes Surg 2011, 21:95–101.
31. Savassi-Rocha AL, Diniz MT, Savassi-Rocha PR, Ferreira JT, Rodrigues de
Almeida Sanches S, Diniz Mde F, Gomes de Barros H, Fonseca IK:
Influence of jejunoileal and common limb length on weight
loss following Roux-en-Y gastric bypass. Obes Surg 2008,
18:1364–1368.
32. Underhill BM: Intestinal length in man. Br Med J 1955, 2:1243–1246.
33. le Roux CW, Welbourn R, Werling M, Osborne A, Kokkinos A, Laurenius A,
Lonroth H, Fandriks L, Ghatei MA, Bloom SR, Olbers T: Gut hormones as
mediators of appetite and weight loss after Roux-en-Y gastric bypass.
Ann Surg 2007, 246:780–785.
34. Stefanidis D, Kuwada TS, Gersin KS: The importance of the length of the
limbs for gastric bypass patients–an evidence-based review. Obes Surg
2011, 21:119–124.
35. Brolin RE, Kenler HA, Gorman JH, Cody RP: Long-limb gastric bypass in the
superobese. A prospective randomized study. Ann Surg 1992,
215:387–395.
36. Pinheiro JS, Schiavon CA, Pereira PB, Correa JL, Noujaim P, Cohen R:
Long-long limb Roux-en-Y gastric bypass is more efficacious in
Grueneberger et al. BMC Surgery 2014, 14:20 Page 8 of 8
http://www.biomedcentral.com/1471-2482/14/20treatment of type 2 diabetes and lipid disorders in super-obese patients.
Surg Obes Relat Dis 2008, 4:521–525. discussion 526-527.
37. Sanchez-Pernaute A, Rubio Herrera MA, Perez-Aguirre E, Garcia Perez JC,
Cabrerizo L, Diez Valladares L, Fernandez C, Talavera P, Torres A: Proximal
duodenal-ileal end-to-side bypass with sleeve gastrectomy: proposed
technique. Obes Surg 2007, 17:1614–1618.
doi:10.1186/1471-2482-14-20
Cite this article as: Grueneberger et al.: Pylorus preserving loop
duodeno-enterostomy with sleeve gastrectomy - preliminary results.
BMC Surgery 2014 14:20.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
